drugset / Trial / NCT04283110

Impact of Adding Midzolam to Bupavicaine 0.5% in Regional Spinal Anaesthesia on Maternal Middle Cerebral Artery Velocimetry in Parturients With Severer Preeclampsia

NCT04283110 ↗

Unknown 100 enrolled Minia University
RandomizedParallel-groupDouble-blindTreatment

Summary

Trial to use GABA mimetic action of midazolam to ameliorate the severe preeclampsia induced neuronal excitotoxicity using middle cerebral artery transcranial doppler resisitive vasculer indices to evaluate . Secondery goal is to study end organ injury

Timeline

Start
2019-01-12
Primary completion
2020-02-17
Completion
2020-04-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule 1 mg Intrathecal